Search

Search Constraints

You searched for: Author/Creator Lagging, Martin

Search Results

1. Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study. (May 2017)

2. Efficacy and safety of 12 weeks versus 18 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin for hepatitis C virus genotype 1 infection in previously untreated patients with cirrhosis and patients with previous null response with or without cirrhosis (C-WORTHY): a randomised, open-label phase 2 trial. Issue 9973 (21st March 2015)

4. Intrahepatic mRNA levels of SOCS1 and SOCS3 are associated with cirrhosis but do not predict virological response to therapy in chronic hepatitis C. (14th November 2012)

8. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study. (May 2022)

9. Imported Case of Lassa Fever in Sweden With Encephalopathy and Sensorineural Hearing Deficit. (20th September 2016)